We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.11B
AUM Growth
+$207M
Cap. Flow
+$183M
Cap. Flow %
2.99%
Top 10 Hldgs %
49.09%
Holding
188
New
51
Increased
37
Reduced
33
Closed
43

Top Sells

Rank Stock Value
1
FIVE icon
Five Below
FIVE
+$67.4M
2
PTCT icon
PTC Therapeutics
PTCT
+$64.3M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$61.2M
4
BURL icon
Burlington
BURL
+$60.4M
5
ROST icon
Ross Stores
ROST
+$42.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.67%
2 Consumer Discretionary 7.86%
3 Consumer Staples 7.27%
4 Technology 5.96%
5 Communication Services 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
26
Iovance Biotherapeutics
IOVA
$1.82B
$57.3M 0.94%
3,000,000
-648,000
-18% -$14.3M
ENR icon
27
Energizer
ENR
$1.44B
$55M 0.9%
1,372,000
-276,000
-17% -$10.6M
TJX icon
28
TJX Companies
TJX
$174B
$52.9M 0.87%
+697,100
New +$48.4M
CENTA icon
29
Central Garden & Pet Co Class A
CENTA
$2.37B
$51.1M 0.84%
1,335,000
+140,000
+12% +$5.18M
CROX icon
30
Crocs
CROX
$6.14B
$50.8M 0.83%
+396,185
New +$61M
UBER icon
31
Uber
UBER
$143B
$50.3M 0.82%
1,200,000
+228,000
+23% +$9.83M
KHC icon
32
Kraft Heinz
KHC
$30.7B
$49M 0.8%
1,364,000
+792,000
+138% +$28.5M
HAE icon
33
Haemonetics
HAE
$3.89B
$46.3M 0.76%
872,000
+122,000
+16% +$7.43M
PARA
34
DELISTED
Paramount Global Class B
PARA
$46M 0.75%
1,524,000
+524,000
+52% +$18.1M
KO icon
35
Coca-Cola
KO
$377B
$44.8M 0.73%
756,000
+156,000
+26% +$8.69M
QDEL icon
36
QuidelOrtho
QDEL
$1.14B
$44.3M 0.72%
+328,000
New +$45.7M
ILMN icon
37
Illumina
ILMN
$31B
$43.8M 0.72%
118,220
+11,308
+11% +$4.28M
MGNX icon
38
MacroGenics
MGNX
$235M
$43.3M 0.71%
+2,700,000
New +$50.8M
ORLY icon
39
O'Reilly Automotive
ORLY
$72.9B
$42.9M 0.7%
911,250
-91,695
-9% -$3.97M
POST icon
40
Post Holdings
POST
$4.14B
$40.1M 0.66%
543,968
+67,232
+14% +$4.61M
PTCT icon
41
PTC Therapeutics
PTCT
$5.68B
$36.5M 0.6%
917,107
-1,678,893
-65% -$64.3M
XRAY icon
42
Dentsply Sirona
XRAY
$2.68B
$34.8M 0.57%
624,000
+404,000
+184% +$22.2M
GOOGL icon
43
Alphabet (Google) Class A
GOOGL
$4.36T
$34.8M 0.57%
240,000
+20,000
+9% +$2.88M
DCPH
44
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$33.5M 0.55%
3,430,154
+2,752,154
+406% +$51.8M
MSFT icon
45
Microsoft
MSFT
$3.45T
$33M 0.54%
98,000
+6,000
+7% +$1.95M
BUD icon
46
AB InBev
BUD
$170B
$32.5M 0.53%
536,000
-400,000
-43% -$23.3M
NTRA icon
47
Natera
NTRA
$38.3B
$29.5M 0.48%
316,000
+100,000
+46% +$10.4M
AHCO icon
48
AdaptHealth
AHCO
$1.47B
$27.8M 0.45%
1,136,000
-188,000
-14% -$4.41M
ATEC icon
49
Alphatec Holdings
ATEC
$1.46B
$26.6M 0.43%
2,324,000
+500,000
+27% +$5.9M
FMTX
50
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$26.4M 0.43%
+1,856,000
New +$32.1M

Similar funds

Armistice Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Armistice Capital held 188 positions worth $6.11B, up 3.5% from $5.9B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Armistice Capital's Q4 2021 filing shows 51 new, 37 increased, 33 reduced and 43 closed positions. Its largest new stake was AutoZone: 38,024 shares worth $79.7M. The largest sale was Five Below, an estimated $67.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q4 2021 buy was AutoZone: 38,024 shares worth $79.7M.
  • Armistice Capital added most to Jazz Pharmaceuticals in Q4 2021, an estimated $72.8M increase.
  • Armistice Capital's biggest Q4 2021 reduction was PTC Therapeutics, cutting an estimated $64.3M.
  • Armistice Capital fully exited Five Below in Q4 2021, selling an estimated $67.4M.
  • Armistice Capital's ten largest holdings make up 49% of its $6.11B portfolio in Q4 2021.
  • Armistice Capital opened 51 new positions and closed 43 in Q4 2021.
  • Armistice Capital's portfolio value rose 3.5% quarter-over-quarter to $6.11B.

Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.